(+)-.alpha.-(2,3-dimethoxyphenyl)-1-[ 2-(4-fluorophenyl)ethyl]-4-piperidinemethanol
US5134149A · kind A · utility
19Cited by
2References
4Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 26, 1991 |
| Grant date | Jul 28, 1992 |
| Priority date | — |
| Expiry date | Jul 26, 2011 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is directed to a new 5HT.sub.2 antagonist, (+)-.alpha.-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidine methanol, and its use in the treatment of a number of disease states.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.